Cargando…
Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide, ranging from steatosis to non-alcoholic steatohepatitis (NASH). Recently, cerium oxide nanoparticles (CeO(2)NPs) have emerged as a new antioxidant agent with hepatoprotective properties in experime...
Autores principales: | Carvajal, Silvia, Perramón, Meritxell, Oró, Denise, Casals, Eudald, Fernández-Varo, Guillermo, Casals, Gregori, Parra, Marina, González de la Presa, Bernardino, Ribera, Jordi, Pastor, Óscar, Morales-Ruíz, Manuel, Puntes, Víctor, Jiménez, Wladimiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731222/ https://www.ncbi.nlm.nih.gov/pubmed/31492960 http://dx.doi.org/10.1038/s41598-019-49262-2 |
Ejemplares similares
-
Cerium Oxide Nanoparticles Protect against Oxidant Injury and Interfere with Oxidative Mediated Kinase Signaling in Human-Derived Hepatocytes
por: Carvajal, Silvia, et al.
Publicado: (2019) -
Cerium Oxide Nanoparticles: A New Therapeutic Tool in Liver Diseases
por: Casals, Gregori, et al.
Publicado: (2021) -
Beyond the Scavenging of Reactive Oxygen Species (ROS): Direct Effect of Cerium Oxide Nanoparticles in Reducing Fatty Acids Content in an In Vitro Model of Hepatocellular Steatosis
por: Parra-Robert, Marina, et al.
Publicado: (2019) -
Cerium oxide nanoparticles improve liver regeneration after acetaminophen-induced liver injury and partial hepatectomy in rats
por: Córdoba-Jover, Bernat, et al.
Publicado: (2019) -
Intrinsic and Extrinsic Properties Affecting Innate Immune Responses to Nanoparticles: The Case of Cerium Oxide
por: Casals, Eudald, et al.
Publicado: (2017)